SAN FRANCISCO (GenomeWeb) – Startup Orbit Genomics plans to develop next-generation sequencing-based assays that analyze microsatellite sequences to diagnose cancer and other diseases.

The Boulder, Colorado-based firm, which was founded last year by CSO Harold Garner, CEO Dede Willis, and others, leverages research done by Garner on microsatellites as well as publicly available genomic databases, like the Cancer Genome Atlas to discover and validate microsatellite markers of disease.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.